{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus du SRAS : Questions médicales les plus fréquentes",
"headline": "Virus du SRAS : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus du SRAS : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus du SRAS"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Betacoronavirus",
"url": "https://questionsmedicales.fr/mesh/D000073640",
"about": {
"@type": "MedicalCondition",
"name": "Betacoronavirus",
"code": {
"@type": "MedicalCode",
"code": "D000073640",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "SARS-CoV-2",
"alternateName": "SARS-CoV-2",
"url": "https://questionsmedicales.fr/mesh/D000086402",
"about": {
"@type": "MedicalCondition",
"name": "SARS-CoV-2",
"code": {
"@type": "MedicalCode",
"code": "D000086402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113.937.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virus du SRAS",
"alternateName": "Severe acute respiratory syndrome-related coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D045473",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Matthew P Cheng",
"url": "https://questionsmedicales.fr/author/Matthew%20P%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre and McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada (M.P.C.)."
}
},
{
"@type": "Person",
"name": "Cedric P Yansouni",
"url": "https://questionsmedicales.fr/author/Cedric%20P%20Yansouni",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.)."
}
},
{
"@type": "Person",
"name": "Michaël Desjardins",
"url": "https://questionsmedicales.fr/author/Micha%C3%ABl%20Desjardins",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital, Boston, Massachusetts, and Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada (M.D.)."
}
},
{
"@type": "Person",
"name": "Sanjat Kanjilal",
"url": "https://questionsmedicales.fr/author/Sanjat%20Kanjilal",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital and Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, Massachusetts (S.K.)."
}
},
{
"@type": "Person",
"name": "Caroline Quach",
"url": "https://questionsmedicales.fr/author/Caroline%20Quach",
"affiliation": {
"@type": "Organization",
"name": "CHU Sainte-Justine, Université de Montréal, Montreal, Canada (C.Q.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Autism spectrum disorder in adulthood].",
"datePublished": "2023-11-09",
"url": "https://questionsmedicales.fr/article/37944552",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1898-5347"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of Autism Spectrum Disorder.",
"datePublished": "2023-05-29",
"url": "https://questionsmedicales.fr/article/37248660",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10731911231173089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Memantine for autism spectrum disorder.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36006807",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013845.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autism Spectrum Disorder and Epilepsy.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36270694",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ncl.2022.03.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder.",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37957611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-023-05362-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN à brin positif",
"item": "https://questionsmedicales.fr/mesh/D000085102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nidovirales",
"item": "https://questionsmedicales.fr/mesh/D028381"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coronaviridae",
"item": "https://questionsmedicales.fr/mesh/D003332"
},
{
"@type": "ListItem",
"position": 7,
"name": "Coronavirus",
"item": "https://questionsmedicales.fr/mesh/D017934"
},
{
"@type": "ListItem",
"position": 8,
"name": "Betacoronavirus",
"item": "https://questionsmedicales.fr/mesh/D000073640"
},
{
"@type": "ListItem",
"position": 9,
"name": "Virus du SRAS",
"item": "https://questionsmedicales.fr/mesh/D045473"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus du SRAS - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus du SRAS",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus du SRAS",
"description": "Comment le SRAS est-il diagnostiqué ?\nQuels tests sont utilisés pour le SRAS ?\nLe SRAS peut-il être confondu avec d'autres maladies ?\nQuels symptômes indiquent un test pour le SRAS ?\nLes radiographies sont-elles utiles pour le SRAS ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus du SRAS",
"description": "Quels sont les symptômes courants du SRAS ?\nLe SRAS provoque-t-il des complications respiratoires ?\nLes symptômes du SRAS apparaissent-ils rapidement ?\nY a-t-il des symptômes gastro-intestinaux associés ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus du SRAS",
"description": "Comment prévenir la transmission du SRAS ?\nLes vaccins contre le SRAS existent-ils ?\nQuelles mesures de quarantaine sont recommandées ?\nLes voyages vers des zones à risque doivent-ils être évités ?\nLes établissements de santé doivent-ils être préparés ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus du SRAS",
"description": "Quel est le traitement principal du SRAS ?\nLes antibiotiques sont-ils efficaces contre le SRAS ?\nLe traitement préventif est-il disponible pour le SRAS ?\nLes corticostéroïdes sont-ils utilisés pour le SRAS ?\nLe soutien respiratoire est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus du SRAS",
"description": "Quelles sont les complications possibles du SRAS ?\nLe SRAS peut-il entraîner des séquelles à long terme ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLe SRAS peut-il causer des problèmes cardiaques ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus du SRAS",
"description": "Qui est le plus à risque de développer le SRAS ?\nLes travailleurs de la santé sont-ils plus exposés ?\nLes voyages dans des zones à risque augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLe contact avec des animaux infectés est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Autism+Spectrum+Disorder#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le SRAS est-il diagnostiqué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, des cultures virales et des analyses sérologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le SRAS ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les tests sérologiques sont couramment utilisés pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il être confondu avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec la grippe ou d'autres infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test pour le SRAS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, dyspnée et antécédents de voyage dans des zones à risque sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles pour le SRAS ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les radiographies thoraciques peuvent montrer des infiltrats pulmonaires caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du SRAS ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux sèche, essoufflement, douleurs musculaires et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Le SRAS provoque-t-il des complications respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner une pneumonie et une détresse respiratoire aiguë."
}
},
{
"@type": "Question",
"name": "Les symptômes du SRAS apparaissent-ils rapidement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 2 à 7 jours après l'exposition au virus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des diarrhées ou des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir la transmission du SRAS ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lavage des mains, le port de masques et l'évitement des contacts étroits sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins contre le SRAS existent-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le SRAS."
}
},
{
"@type": "Question",
"name": "Quelles mesures de quarantaine sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes exposées doivent être mises en quarantaine pour éviter la propagation."
}
},
{
"@type": "Question",
"name": "Les voyages vers des zones à risque doivent-ils être évités ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'éviter les voyages vers des zones où le SRAS est actif."
}
},
{
"@type": "Question",
"name": "Les établissements de santé doivent-ils être préparés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hôpitaux doivent avoir des protocoles pour gérer les cas suspects de SRAS."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du SRAS ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le soutien respiratoire est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le SRAS ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car le SRAS est causé par un virus."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il disponible pour le SRAS ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun traitement préventif spécifique n'est disponible, la prévention repose sur l'hygiène."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés pour le SRAS ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent être utilisés pour réduire l'inflammation dans certains cas."
}
},
{
"@type": "Question",
"name": "Le soutien respiratoire est-il crucial ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien respiratoire est vital pour les patients présentant une détresse respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du SRAS ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, l'insuffisance respiratoire et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des séquelles respiratoires persistantes après guérison."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et celles avec des comorbidités sont plus à risque."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il causer des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le SRAS peut affecter le cœur, entraînant des complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cas de complications neurologiques ont été rapportés chez certains patients atteints de SRAS."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de développer le SRAS ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils plus exposés ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé sont à risque accru en raison de leur exposition aux patients."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le SRAS est présent augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de développer des formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Le contact avec des animaux infectés est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des animaux porteurs du virus peut augmenter le risque d'infection."
}
}
]
}
]
}
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Foundation of Innovative New Diagnostics (FIND), Geneva, Switzerland, and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (S.D.).
McGill Interdisciplinary Initiative in Infection and Immunity, School of Population and Global Health, McGill University, and Montreal Children's Hospital, Montreal, Quebec, Canada (J.P.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Autism is a neurodevelopmental disorder that starts in early childhood and persists over the lifespan. A combination of genetic factors and environmental factors around birth contribute to its etiolog...
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social interaction and communication and the presence of restricted interests and repetitive behaviors. ...
Autism spectrum disorder (ASD; also known as autism) is a developmental disability that begins in childhood and is typically seen in around 1% to 2% of children. It is characterised by social communic...
To assess the effects of memantine on the core symptoms of autism, including, but not limited to, social communication and stereotypical behaviours....
We searched CENTRAL, MEDLINE, Embase, nine other databases and three trials registers up to February 2022. We also checked reference lists of key studies and checked with experts in the field for any ...
We included randomised controlled trials (RCTs) of any dose of memantine compared with placebo in autistic people. We also included RCTs in which only one group received memantine, but both groups rec...
We used standard Cochrane methods. Our primary outcomes were core autism symptoms and adverse effects. Secondary outcomes were language, intelligence, memory, adaptive behaviour, hyperactivity, and ir...
We included three RCTs (two double-blind and one single-blind) with 204 participants that examined the short-term effect (immediately postintervention) of memantine in autistic people. Two studies too...
It is unclear whether memantine is an effective treatment for autistic children. None of the three included trials reported on the effectiveness of memantine in adults. Further studies using rigorous ...
Autism spectrum disorder (ASD), was first described in 1943 as a disorder consisting of a triad of qualitative impairments of social interaction, communication and restricted repetitive patterns of be...
In the Diagnostic and Statistical Manual and Mental Disorders, Fifth Edition (DSM-5), autism spectrum disorder (ASD) and social (pragmatic) communication disorder (SCD) were described as a new categor...
Participants were 127 ASD patients, 52 SCD patients, and 49 NT individuals. Receiver operating characteristic (ROC) analyses were used to examine AQ-J total score cutoff values to distinguish between ...
In the ROC analysis for the ASD and NT groups, the area under the curve (AUC) was 0.96, and the optimum cutoff value was 23 points (sensitivity 92.9%, specificity 85.7%). The AUC for the SCD and NT gr...
Our findings suggest the usefulness of the AQ-J in screening for ASD and SCD....
Individuals with autism spectrum disorder (ASD), in addition to the core features of the disease, experience a higher burden of co-occurring medical conditions. This study sought to describe the frequ...
Autism spectrum disorder is a neurodevelopmental condition marked by restricted interests and difficulty with social communication. ASD is characterized by heightened neuroinflammation and irregular n...
While autism spectrum disorder (ASD) has traditionally been diagnosed in specialty care, rising prevalence rates have strained specialist capacity and created significant diagnostic bottlenecks. With ...